Skip to main content

Showing 21 - 30 of 8120 results

Caring for the Ages

April 6, 2026

Suzetrigine: A First-in-Class Non-Opioid Analgesic — Promise With Vigilance

Suzetrigine (brand name Journavx) is a recently approved, first-in-class, oral, non-opioid analgesic indicated for the treatment of moderate to severe acute pain in adults. Approved by the U.S. Food and Drug Administration (FDA) in 2025, it represents the first novel mechanistic class of oral analgesic in ...
Caring for the Ages

April 6, 2026

Dehydration by Degrees: The Case for Targeted IV Hydration in Long-Term Care

Chronic subclinical hypohydration in SNF residents is real, measurable, and consequential — and the clinical and regulatory framework for addressing it already exists. This article is a response to Nursing Home Parenteral Therapies: Clinical Guidance and Payment Considerations in last month’s Caring for th...
Caring for the Ages

April 6, 2026

Smoking Cessation! What Can I Do?

Endless research has been done to evaluate the factors that initiate and lead to smoking addiction. The teenage years are usually the starting point for most smokers. It begins as a cool thing when company and peer pressure persuade them to perform certain acts. Rationalization and introspection are not th...
Spotlight

April 3, 2026

New Course Prepares PALTC Clinicians for Real-World Practice

Post-acute and long-term care is a specific area of practice, which means clinicians need a unique set of skills to excel. That’s why PALTmed created its new PALTessentials course: Navigating Clinical Practice. Featuring 16 interactive on-demand modules, along with valuable resources and tools, the self-pa...
Policy Snapshot

March 31, 2026

Make Your Voice Heard: Fix Practice Expense Cuts in Skilled Nursing Facilities

Contact the Centers for Medicare & Medicaid Services regarding recent reductions to Practice Expense (PE) RVUs for services in Skilled Nursing Facilities (POS 31). These cuts create an artificial payment difference that does not reflect clinical reality. There is no meaningful difference in the cost of...